# Neogenomics Inc: Form 8-K, filed Feb 20, 2024

- Company: [Neogenomics Inc](/companies/neo.md) (CIK 1077183)
- Form: 8-K
- Filed: 2024-02-20
- Accepted by EDGAR: Feb 20, 2024, 21:06 ET
- Period: 2024-02-20
- Accession: 0001077183-24-000009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1077183/000107718324000009/neo-20240220.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1077183/000107718324000009/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1077183/000107718324000009/neo-20240220.htm

Filed Feb 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001077183-24-000009. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.